UBS Group
SBC

UBS Group’s SBC Medical Group SBC Stock Holding History

UBS Group’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.6K Sell
3,734
-2,030
-35% -$8.47K ﹤0.01% 8112
2025
Q4 		$24.8K Buy
5,764
+3,503
+155% +$13.4K ﹤0.01% 7639
2025
Q3 		$9.81K Sell
2,261
-130
-5% -$586 ﹤0.01% 8576
2025
Q2 		$11.1K Sell
2,391
-58,952
-96% -$233K ﹤0.01% 8800
2025
Q1 		$196K Buy
61,343
+37,604
+158% +$171K ﹤0.01% 6579
2024
Q4 		$132K Buy
23,739
+20,529
+640% +$140K ﹤0.01% 6702
2024
Q3 		$25.6K Buy
3,210
+1,970
+159% +$22.9K ﹤0.01% 7223
2024
Q2 		$16.2K Buy
1,240
+1,189
+2,331% +$15.9K ﹤0.01% 7441
2024
Q1 		$638 Buy
51
+50
+5,000% +$573 ﹤0.01% 8432
2023
Q4 		$11 Sell
1
-57
-98% -$610 ﹤0.01% 9113
2023
Q3 		$619 Buy
58
+48
+480% +$506 ﹤0.01% 8375
2023
Q2 		$103 Sell
10
-4,795
-100% -$49.5K ﹤0.01% 8504
2023
Q1 		$50.1K Buy
4,805
+4,705
+4,705% +$48.6K ﹤0.01% 6454
2022
Q4 		$1.02K Buy
+100
New +$1.01K ﹤0.01% 9989

Other funds holding SBC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group's SBC Position: Q1 2026 in Review

UBS Group reduced its SBC Medical Group (SBC) stake by 35% in Q1 2026, selling an estimated $8.47K and leaving 3,734 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #8112.

UBS Group first reported a position in SBC in Q4 2022 and has held it in 14 quarters since. The position peaked at $196K in Q1 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

  • UBS Group held 3,734 shares of SBC Medical Group worth $15.6K as of Q1 2026.
  • UBS Group sold 2,030 SBC Medical Group shares in Q1 2026, an estimated $8.47K.
  • SBC Medical Group made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8112 holding.
  • UBS Group first reported a position in SBC Medical Group in Q4 2022 and has held it in 14 quarters since.
  • UBS Group's SBC Medical Group position peaked at $196K in Q1 2025.
  • 50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.